Merck said the 5 year OS rate was in favor of KE

Quote:

---

Merck said the 5 year OS rate was in favor of KEYTRUDA ...and is statistically significant @ 86.6% versus 81.7% ...with Chemo alone.
There is about a half dozen players in this space. It will be interesting to see how...and where We stand...on the subject indication.

Investors Hangout: https://investorshangout.com/post/view?id=671...z8mCOKx2Jg

---

so chemo + keytruda only added 5% survival to chemo alone and that is significant? wonder over the years how many people died on keytruda and why there wasnt a hold placed. literally asking for a friend